Activatable photoacoustic-fluorescent dual-mode probe for real-time monitoring of immunotherapy and application of activatable photoacoustic-fluorescent dual-mode probe
A technology for real-time monitoring and immunotherapy, applied in the field of immunomedicine research, which can solve the problems of lack of sensitivity and specificity of early response assessment, heterogeneity of immune response differences, and optimization of unfavorable treatment plans.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Embodiment 1 Construction of activatable probes
[0029] The required granzyme B substrate peptide was synthesized by conventional solid-phase synthesis with the following structure: Gly-Lys(Dabcyl)-Ile-Glu-Pro-Asp-Ala-Pro-Cys(FITC), and analyzed by high performance liquid chromatography The successfully labeled peptides were purified using the method for future use.
[0030] Dissolve 1 mg of the above peptide in 1 ml of ultrapure water, add 0.5 mg of NHS and 0.5 mg of EDC and incubate for 30 minutes to activate the carboxyl group in the peptide. Mix the activated peptide with 1 mg of PDL1 antibody evenly, and then magnetically stir at 200 rpm for 12 hours at room temperature, and reflect in the dark during the whole process. After the reaction is complete, use a 1KD dialysis bag to remove impurities such as free polypeptides by dialysis, and recover the antibody.
[0031] Described probe synthesis HPLC report sees attached figure 1 As shown, it can be seen that the ...
Embodiment 2
[0032] Schematic diagram of the working principle of the probe described in embodiment 2
[0033] The activatable photoacoustic-fluorescence dual-mode probe for real-time monitoring of immunotherapy according to the present invention is composed of a PDL1 antibody and a granzyme B substrate peptide, and the surface of the granzyme B substrate peptide is modified with a fluorescent group and A quenching group, the probe is an activatable photoacoustic / fluorescence dual-mode probe based on the PDL1 antibody, and is used for monitoring the activity of granzyme B.
[0034] Such as figure 2 The schematic diagram shown, after intravenous injection of the composite probe, the PDL1 antibody actively targets the tumor surface PDL1 protein (eg figure 2 In a), the anti-tumor immunity of T cells is activated by blocking the interaction between PDL1 and PD1 on the surface of T cells, and the activated T cells release granzyme B to kill tumors (such as figure 2 middle b); at the same t...
Embodiment 3
[0035] Example 3 Probe Functional Activity Characterization
[0036] Incubate the probe-labeled antibody with different concentrations (0-1mg / ml) of recombinant granzyme B for 10 minutes, and detect the fluorescence intensity at 460nm excitation and 480-600nm range by a microplate reader to verify the different probe pairs Signal response characteristics of different concentrations of granzyme B.
[0037] Such as image 3 The changes in fluorescence intensity after incubation with different granzyme concentrations and the probe for the same time indicated, it can be seen that the probe can sensitively detect granzyme B activity and is positively correlated with granzyme B concentration.
[0038] Continue to co-incubate the probe-labeled antibody with 100ng / ml recombinant granzyme B, and detect the signal response characteristics of the probe at different incubation times (0-130min) by a microplate reader.
[0039] Such as Figure 4 The change of the fluorescence intensity a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com